{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Syn X Pharma", "item": "https://www.patentleaderboard.com/2021/company/syn-x-pharma"}, {"@type": "ListItem", "position": 4, "name": "John Marshall", "item": "https://www.patentleaderboard.com/2021/inventor/fl:jo_ln:marshall-36"}]}

Home › 2021 › Syn X Pharma › John Marshall

John Marshall — 1 Patent in 2021

GEGenzyme: 1 patents #20 of 122Top 20%

Chicago, IL: #517 of 1,816 inventorsTop 30%

Illinois: #2,747 of 8,822 inventorsTop 35%

Overall (2021): #395,433 of 548,734Top 75%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
11008316	Glucosylceramide synthase inhibitors	Elyse Bourque, Mario CABRERA-SALAZAR, Cassandra Celatka, Seng H. Cheng, Bradford H. Hirth +12 more	2021-05-18

John Marshall — 1 Patent in 2021

Issued Patents 2021

Patent Widget